EA200501764A3 - Preparation for the treatment of joint diseases - Google Patents

Preparation for the treatment of joint diseases

Info

Publication number
EA200501764A3
EA200501764A3 EA200501764A EA200501764A EA200501764A3 EA 200501764 A3 EA200501764 A3 EA 200501764A3 EA 200501764 A EA200501764 A EA 200501764A EA 200501764 A EA200501764 A EA 200501764A EA 200501764 A3 EA200501764 A3 EA 200501764A3
Authority
EA
Eurasian Patent Office
Prior art keywords
treatment
preparation
joint diseases
diseases
tool
Prior art date
Application number
EA200501764A
Other languages
Russian (ru)
Other versions
EA007808B1 (en
EA200501764A2 (en
Inventor
Сергей Ефимович Васюков
Татьяна Юрьевна Александрова
Андрей Леонидович Младенцев
Рустам Мунирович Иксанов
Original Assignee
Открытое Акционерное Общество "Нижегородский Химико-Фармацевтический Завод" (Оао "Нижфарм")
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Открытое Акционерное Общество "Нижегородский Химико-Фармацевтический Завод" (Оао "Нижфарм") filed Critical Открытое Акционерное Общество "Нижегородский Химико-Фармацевтический Завод" (Оао "Нижфарм")
Publication of EA200501764A2 publication Critical patent/EA200501764A2/en
Publication of EA200501764A3 publication Critical patent/EA200501764A3/en
Publication of EA007808B1 publication Critical patent/EA007808B1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Изобретение относится к области медицины, а именно к препаратам наружного применения для лечения болезней суставов. Предлагаемое средство содержит сахарид - соль глюкозамина (0,5-10 мас.%) и диметилсульфоксид (1,0-20 мас.%), включенных в приемлемую мазевую основу. Данное средство является эффективным за счет использования низкомолекулярных сахаридов и, как следствие, увеличения скорости диффузии активной субстанции в зону сустава.The invention relates to medicine, namely to drugs external use for the treatment of diseases of the joints. The proposed tool contains saccharide - salt of glucosamine (0.5-10 wt.%) And dimethyl sulfoxide (1.0-20 wt.%) Included in an acceptable ointment base. This tool is effective due to the use of low molecular saccharides and, as a consequence, an increase in the rate of diffusion of the active substance into the joint zone.

EA200501764A 2004-10-12 2005-12-07 Preparation for the treatment of joint diseases EA007808B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2004129984/15A RU2271811C1 (en) 2004-10-12 2004-10-12 Agent for treatment of joint disease

Publications (3)

Publication Number Publication Date
EA200501764A2 EA200501764A2 (en) 2006-04-28
EA200501764A3 true EA200501764A3 (en) 2006-06-30
EA007808B1 EA007808B1 (en) 2007-02-27

Family

ID=36117166

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200501764A EA007808B1 (en) 2004-10-12 2005-12-07 Preparation for the treatment of joint diseases

Country Status (2)

Country Link
EA (1) EA007808B1 (en)
RU (1) RU2271811C1 (en)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2021811C1 (en) * 1992-09-01 1994-10-30 Васюков Сергей Ефимович Agent for joint disease treatment showing antiinflammatory and analgesic effect
US6482401B1 (en) * 1998-12-23 2002-11-19 Naturopathic Laboratories International, Inc. Composition for the relief of joint pain and myofascial pain and method of preparing same
US20030109495A1 (en) * 2001-08-27 2003-06-12 Kretschmer Louis Frank Nutraceutical solutions comprising dimethyl sulfoxide
US20030125303A1 (en) * 2001-12-28 2003-07-03 Andrew Kucharchuk Transdermal formulation for repair and maintenance of connective tissue

Also Published As

Publication number Publication date
RU2271811C1 (en) 2006-03-20
EA007808B1 (en) 2007-02-27
EA200501764A2 (en) 2006-04-28

Similar Documents

Publication Publication Date Title
CY1116215T1 (en) Combination therapy for the therapeutic treatment of Protein Deficiency Disorders
DE60236541D1 (en) INHIBITORS OF 11-BETA-HYDROXYSTEROIDDEHYDROGENASE TYPE 1
DK1317419T3 (en) Cyanophenoxycarboxylic acid compounds and compositions to deliver active agents
RU2325389C2 (en) Composition and derivatives of substituted azaindoloxoacetapiperazine characterized by antiviral activity
WO2003096990A3 (en) Protein cages for the delivery of medical imaging and therapy
DE602006014990D1 (en) INTRANASAL ADMINISTRATION OF FAST-ACTING INSULIN
DE602005021770D1 (en) INDOLE-1-YL-ACETIC DERIVATIVES
NO20062504L (en) Compositions and dosage forms for improved absorption
EA200501849A1 (en) DERIVATIVES OF PYRAZOLOHINAZOLINE: METHOD FOR OBTAINING AND USING AS KINAZ INHIBITORS
CU23208A3 (en) OXAZOLIDINONAS REPLACED AND ITS USE IN THE FIELD OF THE SANGUINEA COAGULATION
EA200970595A1 (en) DERIVATIVES OF SUBSTITUTED INDAZOLS ACTIVE AS KINAZ INHIBITORS
EA200601747A1 (en) THREE (CYCLO) SUBSTITUTED AMIDA COMPOUNDS
EA200601799A1 (en) HYDRAZIDE-CONTAINING COMPOUNDS - CFTR INHIBITORS AND THEIR APPLICATION
SE0001899D0 (en) New compounds
CY1112376T1 (en) 2,3,4,9-tetrahydro-1H-carvasol derivative as CRTH2 receptor antagonists
SE0100568D0 (en) Compounds
NO20064186L (en) Substituted pyrazoline compositions to reduce blood triglycerides
BRPI0611705A2 (en) compound or a pharmaceutically acceptable salt thereof, pharmaceutical composition, and use of compound
NO20043367L (en) Oral pharmaceutical preparation
EA200800360A1 (en) FORMS WITH HIGH CONTENT OF DRUGS AND DOSED FORMS
BRPI0418099A (en) compounds, pharmaceutical composition, and use of a compound
WO2007064448A3 (en) Cancer treatment using fts and 2-deoxyglucose
WO2005016867A3 (en) Anthranilic acid derivatives and their use as activators of the hm74a receptor
DE50203456D1 (en) DEUTERATED 3-PIPERIDINOPROPIOPHENONE AND MEDICAMENTS CONTAINING SUCH COMPOUNDS
EA200500941A1 (en) MEANS FOR TREATING JOINT DISEASES

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): RU

TC4A Change in name of a patent proprietor in a eurasian patent
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM